Skip to main content
OpenTrials

Clinical trial condition

Geographic Atrophy Secondary to Age-related Macular Degeneration

Explore clinical trials studying Geographic Atrophy Secondary to Age-related Macular Degeneration. Study availability and eligibility vary by location and protocol.

11 public trials 8 recruiting studies
Refine in advanced search Browse all conditions

Geographic Atrophy Secondary to Age-related Macular Degeneration trial results

Recruiting

Safety and Clinical Applicability of Transcorneal Electrical Stimulation (TES) in Geographic Atrophy

NCT07531927

Conditions
Eye Diseases, Geographic Atrophy, Geographic Atrophy Secondary to Age-related Macular Degeneration, +3 more
Locations
  • Department of Ophthalmology, University Medical Center Hamburg-Eppendorf Hamburg, Germany
  • Department of Ophthalmology, Ludwig-Maximilians-University Munich München, Germany
  • Department of Ophthalmology, Klinikum Stuttgart Stuttgart, Germany
  • Centre for Ophthalmology, University Hospital Tuebingen Tübingen, Germany
View Trial Details
Recruiting

Microcurrent Stimulation Therapy for Intermediate to Advanced Nonexudative Age-related Macular Degeneration

NCT06662162

Conditions
Age-Related Macular Degeneration, Age-Related Macular Degeneration (ARMD), Eye Diseases, +6 more
Locations
  • Retina Consultants PC Manchester, Connecticut, United States
  • University Retina & Macula Associates Lemont, Illinois, United States
  • Sierra Eye Associates Reno, Nevada, United States
  • Texas Retina Associates Fort Worth, Texas, United States
View all 15 locations
View Trial Details
Recruiting

A Non-Interventional Study Observing Short-Term Progression in Geographic Atrophy (GA)

NCT07144137

Conditions
Eye Diseases, Geographic Atrophy, Geographic Atrophy Secondary to Age-related Macular Degeneration, +3 more
Locations
  • Northern California Retina Vitreous Associates Medical Group Mountain View, California, United States
  • University Retina and Macula Associates Oak Forest, Illinois, United States
  • Midwest Eye Institute Carmel, Indiana, United States
  • Sierra Eye Associates Reno, Nevada, United States
View all 13 locations
View Trial Details
Recruiting

A Study to Investigate Efficacy and Safety of FWY003 Compared With Placebo in Participants With Geographic Atrophy Secondary to Age-related Macular Degeneration

NCT07441642

Conditions
Geographic Atrophy Secondary to Age-related Macular Degeneration
Locations
  • Salehi Retina Institute Huntington Beach, California, United States
  • Retinal Consultants Medical Group Inc Sacramento, California, United States
  • California Retina Consultants Santa Barbara, California, United States
  • Advanced Research LLC Boynton Beach, Florida, United States
View all 51 locations
View Trial Details
Recruiting

A Phase 2, Randomized, Placebo Controlled, Multicenter, Masked Study to Evaluate the Efficacy, Safety, Tolerability, and Pharmacodynamics of Multidose APL 3007 in Combination With Syfovre/Pegcetacoplan (APL-2) in Patients Diagnosed With Geographic Atrophy Secondary to Age Related Macular Degeneratio

NCT07215390

Conditions
Geographic Atrophy Secondary to Age-related Macular Degeneration
Locations
  • Associated Retina Consultants (01065) Gilbert, Arizona, United States
  • Barnet Dulaney Perkins Eye Center (01018) Mesa, Arizona, United States
  • Associated Retina Consultants - Phoenix Phoenix, Arizona, United States
  • Retinal Research Institute, LLC (01021) Phoenix, Arizona, United States
View all 78 locations
View Trial Details
Recruiting

An Optimised GA Interventional Trial (Opti-GAIN) to Test if Treatment With CTx001 is Safe and Works for People With Geographic Atrophy (GA)

NCT07392255

Conditions
Geographic Atrophy Secondary to Age-related Macular Degeneration
Locations
  • Midwest Eye Institute Carmel, Indiana, United States
  • Sierra Eye Associates Reno, Nevada, United States
  • Retina Foundation of the Southwest Dallas, Texas, United States
  • Gundersen Health System La Crosse, Wisconsin, United States
View Trial Details
Recruiting

Phase 2 Study of ADX-038 in Participants With Geographic Atrophy

NCT06990269

Conditions
Geographic Atrophy Secondary to Age-related Macular Degeneration
Locations
  • ADARx Clinical Site Gilbert, Arizona, United States
  • ADARx Clinical Site Phoenix, Arizona, United States
  • ADARx Clinical Site Bakersfield, California, United States
  • ADARx Clinical Site Beverly Hills, California, United States
View all 27 locations
View Trial Details
Completed

An Extension Study to Evaluate the Long-term Safety and Efficacy of Pegcetacoplan (APL-2) in Subjects With Geographic Atrophy Secondary to AMD

NCT04770545

Conditions
Geographic Atrophy Secondary to Age-related Macular Degeneration
Locations
  • Retinal Research Institue, LLC Phoenix, Arizona, United States
  • Associated Retina Consultants, Ltd. Phoenix, Arizona, United States
  • California Retina Consultants Bakersfield, California, United States
  • Retinal Diagnostic Center Campbell, California, United States
View all 175 locations
View Trial Details

Related conditions